Lipigon Pharmaceuticals' market value is the price at which a share of Lipigon Pharmaceuticals trades on a public exchange. It measures the collective expectations of Lipigon Pharmaceuticals AB investors about its performance. Lipigon Pharmaceuticals is selling for under 0.18 as of the 17th of March 2025; that is 5.88 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.16. With this module, you can estimate the performance of a buy and hold strategy of Lipigon Pharmaceuticals AB and determine expected loss or profit from investing in Lipigon Pharmaceuticals over a given investment horizon. Check out Lipigon Pharmaceuticals Correlation, Lipigon Pharmaceuticals Volatility and Lipigon Pharmaceuticals Alpha and Beta module to complement your research on Lipigon Pharmaceuticals.
Please note, there is a significant difference between Lipigon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipigon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipigon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lipigon Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lipigon Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lipigon Pharmaceuticals.
0.00
12/17/2024
No Change 0.00
0.0
In 2 months and 31 days
03/17/2025
0.00
If you would invest 0.00 in Lipigon Pharmaceuticals on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Lipigon Pharmaceuticals AB or generate 0.0% return on investment in Lipigon Pharmaceuticals over 90 days. Lipigon Pharmaceuticals is related to or competes with Sprint Bioscience, BioArctic, Veg Of, and Ascelia Pharma. Lipigon Pharmaceuticals AB develops drugs for lipid related diseases in Sweden More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lipigon Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lipigon Pharmaceuticals AB upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipigon Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lipigon Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Lipigon Pharmaceuticals historical prices to predict the future Lipigon Pharmaceuticals' volatility.
Lipigon Pharmaceuticals appears to be out of control, given 3 months investment horizon. Lipigon Pharmaceuticals has Sharpe Ratio of 0.0433, which conveys that the firm had a 0.0433 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Lipigon Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Lipigon Pharmaceuticals' Risk Adjusted Performance of 0.0547, mean deviation of 6.05, and Downside Deviation of 9.96 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lipigon Pharmaceuticals holds a performance score of 3. The company secures a Beta (Market Risk) of -0.78, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Lipigon Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Lipigon Pharmaceuticals is likely to outperform the market. Please check Lipigon Pharmaceuticals' treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Lipigon Pharmaceuticals' current price movements will revert.
Correlation Coefficient
0.0
Spearman Rank Test
-0.07
Residual Average
0.0
Price Variance
0.0
Lipigon Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Lipigon Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lipigon Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Lipigon Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Lipigon Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Lipigon Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lipigon Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lipigon Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lipigon Pharmaceuticals stock over time.
Current vs Lagged Prices
Timeline
Lipigon Pharmaceuticals Lagged Returns
When evaluating Lipigon Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lipigon Pharmaceuticals stock have on its future price. Lipigon Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lipigon Pharmaceuticals autocorrelation shows the relationship between Lipigon Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Lipigon Pharmaceuticals AB.
Regressed Prices
Timeline
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Lipigon Pharmaceuticals' price analysis, check to measure Lipigon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipigon Pharmaceuticals is operating at the current time. Most of Lipigon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lipigon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipigon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lipigon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.